
|Articles|August 18, 2008
FDA clears Iridex IQ Laser Systems
Mountain view, Calif. - Iridex Corporation says it has received clearance from the U.S. Food and Drug Administration (FDA) for its IQ Laser Systems, according to BioOptics World.
Advertisement
Mountain view, Calif.
- Iridex Corporation says it has received clearance from the U.S. Food and Drug Administration (FDA) for its IQ Laser Systems, according to BioOptics World.
The clearance is for specific applications in dermatology as well as ophthalmology and ENT/otolaryngology. It covers the Iridex IQ 532 (green laser), IQ 577 (yellow), IQ 630-670 (red) and IQ 810 (infrared) laser products.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
FDA Clears IND Application of Recludix’s Oral STAT6, REX-8756
3
Practical Approaches to Managing Atopic Dermatitis With Topical Therapies
4
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
5

















